Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea.

Frontline Gastroenterol · 2011 · PMC3009417 · PMID 22095308

Europe PMC DOI

hedged sentence

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

did not reach statistical significancep=0.078so close (0.05 < p ≤ 0.1)

By intention to treat analysis, which includes those patients who dropped out, 30/49 (61%) would have chosen enzymes while 19/49 (39%) would have selected the placebo, trending towards a definite benefit for enzymes although the p value did not reach statistical significance (p=0.078).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.